Research and Development

In the first ever study of its kind, researchers from the University of Surrey examined the records of more than …

Gilead had revealed that it has promoted Dr Alessandro Riva, its Senior Vice President, Hematology and Oncology Therapeutic Area Head, …

New findings of a report by PwC have revealed the biggest spenders in R&D worldwide as global spending hits $700 …

The November edition of Pharmafocus is now live and available to read online here!

Recipharm, a leading contract development and manufacturing organisation (CDMO) has equipped its sixth facility with serialisation capabilities ahead of the …

Ben Hargreaves examines the emerging practical and technological solutions that are aiming to improve patients’ access to medicines in a …

Another week gone, and it’s deadline day here at Pharmafocus, meaning you can look forward to our November issue next …

Research from scientists at the Wellcome Trust Sanger Institute has found that only between one and 10 genetic mutations are …

Celgene took a gamble when it spent $710 million up-front on an inflammatory disorder treatment, but it now looks likely …

Peter Naredi, of ECCO, explores how a multi-dimensional approach is necessary to ensure that patients receive access to the most …

Eli Lilly has announced it is to partner up with CureVac to leverage its proprietary RNActive technology in order to …

The first-ever trial to treat patients for rare cancers in a personalised manner based on the characteristics of their individual …

 Scientists at MIT’s Computer Science and Artificial Intelligence Laboratory have developed a machine learning AI system that is able diagnose …

Novartis has announced its intention to shut down its US generics manufacturing plant in Broomfield, Colorado, a move that will …

Two studies published separately by the BBC and the Care Quality Commission (CQC) point to growing problems across NHS services …